TapewireFind a company

person · Reporting owner

HIGDON LEO I JR

Disclosed activity across 5 companies

Tapewire entity
17522
SEC CIK
0001064587

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CITIZENS FINANCIAL GROUP INC/RICFG · Entity 1913DirectorFebruary 11, 2022February 14, 2022
Encompass Health CorpEHC · Entity 3460DirectorApril 18, 2022April 20, 2022
Enhabit, Inc.EHAB · Entity 46765DirectorJune 28, 2023June 30, 2023
NEWMONT Corp /DE/NEM · Entity 1894DirectorJune 15, 2005June 17, 2005

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CITIZENS FINANCIAL GROUP INC/RI

Report date February 11, 2022 · Filed February 14, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect33,766.875 Reported balance After 2022-02-11 transaction · row 1
1 source row

Row 1 · 2022-02-11 · Grant · Acquired 129.59 · Balance 33,766.875

F1: Reflects restricted stock units credited to the reporting person's account following the issuer's dividend payment, pursuant to an award granted to the filer pursuant to the Citizens Financial Group, Inc. 2014 Non-Employee Directors Compensation Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects restricted stock units credited to the reporting person's account following the issuer's dividend payment, pursuant to an award granted to the filer pursuant to the Citizens Financial Group, Inc. 2014 Non-Employee Directors Compensation Plan.

Encompass Health Corp

Report date April 18, 2022 · Filed April 20, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Encompass Health Common StockSEC Table I · non-derivativeDirect5,104 Reported balance After 2022-04-18 transaction · row 1
1 source row

Row 1 · 2022-04-18 · Grant · Acquired 298 · Balance 5,104

F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Encompass Health Common StockSEC Table I · non-derivativeIndirectBy irrevocable trust for the benefit of spouse and issue75,287 Reported balance Holding disclosure · report date 2022-04-18 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 75,287

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Enhabit, Inc.

Report date June 28, 2023 · Filed June 30, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect29,776 Reported balance After 2023-06-28 transaction · row 1
1 source row

Row 1 · 2023-06-28 · Grant · Acquired 12,702 · Balance 29,776

Common StockSEC Table I · non-derivativeIndirectBy 2016 Exempt Family Trust7,926 Reported balance Holding disclosure · report date 2023-06-28 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 7,926

NEWMONT Corp /DE/

Report date June 15, 2005 · Filed June 17, 2005

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $1.60 par valueSEC Table I · non-derivativeDirect9,563 Reported balance After 2005-06-15 transaction · row 1
1 source row

Row 1 · 2005-06-15 · Grant · Acquired 1,303 · Balance 9,563

F1: Pursuant to the 2005 Stock Incentive Plan for Newmont Mining Corporation (the "Company") the reporting person was awarded director stock units that are immediately fully vested and entitle the reporting person to receive 1,303 shares of the Company's common stock which are issued upon retirement from the board of directors of the Company.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the 2005 Stock Incentive Plan for Newmont Mining Corporation (the "Company") the reporting person was awarded director stock units that are immediately fully vested and entitle the reporting person to receive 1,303 shares of the Company's common stock which are issued upon retirement from the board of directors of the Company.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Mirror Merger Sub 2, LLC

Report date March 01, 2021 · Filed March 03, 2021

Section 16 reporting ended · disclosed 2021-03-03. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Eaton Vance Corp. Non-voting Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2021-03-01 transaction · row 1
1 source row

Row 1 · 2021-03-01 · Disposition to issuer · Disposed 8,923 · Balance 0

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of October 7, 2020 (the Merger Agreement), by and among Issuer, Morgan Stanley, Mirror Merger Sub 1, Inc. and Mirror Merger Sub 2, LLC, in exchange for $200,349.38 and 5,879 shares of Morgan Stanley Common Stock having a market value of $79.16 per share on the Effective Date of the Merger.

Deferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2021-03-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2021-03-01 · Disposition to issuer · Disposed 5,840 · Balance 0

F2: Each Deferred Stock Unit is the economic equivalent of one share of non-voting common stock.

F3: This Deferred Stock Unit award was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $426,320.00.

Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.46 · Expires 2021-11-01Direct0 Reported balance After 2021-03-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2021-03-01 · Disposition to issuer · Disposed 6,420 · Balance 0

F4: This option award, which was granted on November 1, 2011, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $311,629.56.

Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.23 · Expires 2022-11-01Direct0 Reported balance After 2021-03-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2021-03-01 · Disposition to issuer · Disposed 5,680 · Balance 0

F5: This option award, which was granted on November 1, 2012, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $254,310.13.

Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.90 · Expires 2023-11-01Direct0 Reported balance After 2021-03-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2021-03-01 · Disposition to issuer · Disposed 4,045 · Balance 0

F6: This option award, which was granted on November 1, 2013, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $125,799.50.

Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.84 · Expires 2026-11-01Direct0 Reported balance After 2021-03-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2021-03-01 · Disposition to issuer · Disposed 11,777 · Balance 0

F7: This option award, which was granted on November 1, 2016, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $449,410.32.

Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.76 · Expires 2025-11-02Direct0 Reported balance After 2021-03-01 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2021-03-01 · Disposition to issuer · Disposed 7,451 · Balance 0

F8: This option award, which was granted on November 2, 2015, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $270,024.24.

Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.71 · Expires 2024-11-03Direct0 Reported balance After 2021-03-01 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2021-03-01 · Disposition to issuer · Disposed 5,737 · Balance 0

F9: This option award, which was granted on November 3, 2014, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $208,195.73.

Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2021-03-01 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2021-03-01 · Disposition to issuer · Disposed 3,252 · Balance 0

F10: Each Phantom Stock Unit is the economic equivalent of one share of non-voting common stock.

F11: This Phantom Stock Unit award, which was granted on November 1, 2017, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $237,396.00.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of October 7, 2020 (the Merger Agreement), by and among Issuer, Morgan Stanley, Mirror Merger Sub 1, Inc. and Mirror Merger Sub 2, LLC, in exchange for $200,349.38 and 5,879 shares of Morgan Stanley Common Stock having a market value of $79.16 per share on the Effective Date of the Merger.

F2: Each Deferred Stock Unit is the economic equivalent of one share of non-voting common stock.

F3: This Deferred Stock Unit award was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $426,320.00.

F4: This option award, which was granted on November 1, 2011, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $311,629.56.

F5: This option award, which was granted on November 1, 2012, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $254,310.13.

F6: This option award, which was granted on November 1, 2013, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $125,799.50.

F7: This option award, which was granted on November 1, 2016, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $449,410.32.

F8: This option award, which was granted on November 2, 2015, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $270,024.24.

F9: This option award, which was granted on November 3, 2014, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $208,195.73.

F10: Each Phantom Stock Unit is the economic equivalent of one share of non-voting common stock.

F11: This Phantom Stock Unit award, which was granted on November 1, 2017, was canceled and converted in the Merger into the right to receive a cash payment of $73 per share for a total of $237,396.00.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 01, 2016 Filed Nov 2, 2016 18:42 UTC Mirror Merger Sub 2, LLC EV · Entity 141944 GrantOption (right to buy) · Derivative 11,777 $0.00 Strike: $34.84 $0.00
Disclosure

SEC source: 0001225208-16-041043 · doc4.xml · derivative · entry 2

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,777

Underlying: Eaton Vance Corp. Non-voting Common Stock · 11,777 shares

Expires 2026-11-01

Read SEC document
October 24, 2016 Filed Oct 26, 2016 12:38 UTC Mirror Merger Sub 2, LLC EV · Entity 141944 Exercise / conversionOption (right to buy) · Derivative 8,197 $0.00 Strike: $29.39 $0.00
Disclosure

SEC source: 0001225208-16-040755 · doc4.xml · derivative · entry 3

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Eaton Vance Corp. Non-voting Common Stock · 8,197 shares

Expires 2016-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 24, 2016 Filed Oct 26, 2016 12:38 UTC Mirror Merger Sub 2, LLC EV · Entity 141944 SaleEaton Vance Corp. Non-voting Common Stock 8,197 $37.66 $308,703.94
Disclosure

SEC source: 0001225208-16-040755 · doc4.xml · nonDerivative · entry 2

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,756

Read SEC document
October 24, 2016 Filed Oct 26, 2016 12:38 UTC Mirror Merger Sub 2, LLC EV · Entity 141944 Exercise / conversionEaton Vance Corp. Non-voting Common Stock 8,197 $29.39 $240,897.53
Disclosure

SEC source: 0001225208-16-040755 · doc4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,953

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 17, 2016 Filed Oct 19, 2016 17:58 UTC Encompass Health Corp HLS · Entity 3460 GrantHealthsouth Common Stock 346 $0.00 $0.00
Disclosure

SEC source: 0001127602-16-065004 · form4.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,193

F1 · shares: Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 17, 2016, HealthSouth paid a dividend on its common stock of $0.24 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Read SEC document
June 15, 2005 Filed Jun 17, 2005 17:05 UTC NEWMONT Corp /DE/ NEM · Entity 1894 GrantCommon Stock, $1.60 par value 1,303 $38.37 $49,996.11
Disclosure

SEC source: 0001164727-05-000104 · edgar.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,563

F1 · kind: Pursuant to the 2005 Stock Incentive Plan for Newmont Mining Corporation (the "Company") the reporting person was awarded director stock units that are immediately fully vested and entitle the reporting person to receive 1,303 shares of the Company's common stock which are issued upon retirement from the board of directors of the Company.

Read SEC document
April 28, 2004 Filed Apr 30, 2004 11:14 UTC NEWMONT Corp /DE/ NEM · Entity 1894 OtherCommon Stock, $1.60 par value 655 $38.15 $24,988.25
Disclosure

SEC source: 0001164727-04-000072 · edgar.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,260

F1 · kind: Award of 655 shares pursuant to Issuer's 2000 Non-Employee Directors Stock Plan.

Read SEC document
May 07, 2003 Filed May 9, 2003 13:14 UTC NEWMONT Corp /DE/ NEM · Entity 1894 OtherCommon Stock, $1.60 par value 877 $28.50 $24,994.50
Disclosure

SEC source: 0001164727-03-000081 · edgar.xml · nonDerivative · entry 1

HIGDON LEO I JR · CIK 0001064587 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,605

F1 · kind: Award of 877 shares pursuant to Issuer's 2000 Non-Employee Directors Stock Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.